FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of Genticel

Genticel Announces Positive Preclinical Proof of Concept Results for HPV Therapeutic Vaccine Candidate

03-Jun-2015 - Genticel announced positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company’s versatile Vaxiclase platform.No treatment options are available for women infected with oncogenic HPV types but who have not yet developed ...

endometrial cancer HPV vaccines

Genticel granted five new patents in the US and Asia during first half of 2014

31-Jul-2014 - Genticel has been granted five patents in major territories since the beginning of 2014. These patents consolidate Genticel’s product pipeline in important emerging and mature pharmaceutical markets. The patents US 8628779, IN 258906 and KR 10-1382250, granted in the USA, India and South Korea ...

patents vaccines

Genticel names Dr Didier Hoch, former president of Sanofi-Pasteur MSD, to its supervisory board

12-Jul-2011 - Genticel announced that it has appointed Dr Didier Hoch as member of the company’s supervisory board (conseil de surveillance).Dr Hoch brings his outstanding experience of over 25 years in the pharmaceutical industry to Genticel. Dr Hoch’s successful career in the vaccine industry includes ten ...

Genticel’s therapeutic vaccine ProCervix receives clearance to start a Phase I clinical trial

27-Jul-2010 - Genticel announced that it has obtained approval to start a Phase 1 clinical trial with its candidate therapeutic HPV vaccine on adult women already infected with human papillomavirus (HPV). The clinical trial will take place in Belgium starting Q3 2010. Belgium’s Federal Agency for Medicines ...

Belgium clinical trials immunogenicity +4